vs

Side-by-side financial comparison of CAPRICOR THERAPEUTICS, INC. (CAPR) and Chanson International Holding (CHSN). Click either name above to swap in a different company.

CAPRICOR THERAPEUTICS, INC. is the larger business by last-quarter revenue ($11.1M vs $8.7M, roughly 1.3× Chanson International Holding). Chanson International Holding runs the higher net margin — -12.1% vs -63.9%, a 51.9% gap on every dollar of revenue. On growth, Chanson International Holding posted the faster year-over-year revenue change (15.2% vs -7.9%).

Capricor Therapeutics is a clinical-stage biotechnology company focused on discovering, developing and commercializing innovative biological therapies including cell and gene therapies for rare diseases, cardiovascular disorders and muscular conditions. It primarily operates in the U.S. market, addressing unmet medical needs for patient groups with limited treatment options.

Chanson International Holding is a food and beverage enterprise focused on operating premium bakery chains primarily across mainland China. Its product portfolio includes freshly baked bread, handcrafted pastries, custom celebration cakes, specialty beverages, and frozen bakery goods supplied to partnered retail outlets, catering to middle-class consumers with demand for high-quality daily food options.

CAPR vs CHSN — Head-to-Head

Bigger by revenue
CAPR
CAPR
1.3× larger
CAPR
$11.1M
$8.7M
CHSN
Growing faster (revenue YoY)
CHSN
CHSN
+23.1% gap
CHSN
15.2%
-7.9%
CAPR
Higher net margin
CHSN
CHSN
51.9% more per $
CHSN
-12.1%
-63.9%
CAPR

Income Statement — Q4 FY2024 vs Q2 FY2025

Metric
CAPR
CAPR
CHSN
CHSN
Revenue
$11.1M
$8.7M
Net Profit
$-7.1M
$-1.0M
Gross Margin
44.5%
Operating Margin
-69.1%
-13.7%
Net Margin
-63.9%
-12.1%
Revenue YoY
-7.9%
15.2%
Net Profit YoY
-833.8%
-4579.7%
EPS (diluted)
$-0.11
$-2.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAPR
CAPR
CHSN
CHSN
Q2 25
$8.7M
Q4 24
$11.1M
Q3 24
$2.3M
Q2 24
$4.0M
$7.5M
Q1 24
$4.9M
Q4 23
$12.1M
Q3 23
$6.2M
Q2 23
$3.9M
Net Profit
CAPR
CAPR
CHSN
CHSN
Q2 25
$-1.0M
Q4 24
$-7.1M
Q3 24
$-12.6M
Q2 24
$-11.0M
$23.4K
Q1 24
$-9.8M
Q4 23
$-762.1K
Q3 23
$-6.4M
Q2 23
$-7.4M
Gross Margin
CAPR
CAPR
CHSN
CHSN
Q2 25
44.5%
Q4 24
Q3 24
Q2 24
41.5%
Q1 24
Q4 23
Q3 23
Q2 23
Operating Margin
CAPR
CAPR
CHSN
CHSN
Q2 25
-13.7%
Q4 24
-69.1%
Q3 24
-575.2%
Q2 24
-291.9%
-7.4%
Q1 24
-209.2%
Q4 23
-10.6%
Q3 23
-111.0%
Q2 23
-197.8%
Net Margin
CAPR
CAPR
CHSN
CHSN
Q2 25
-12.1%
Q4 24
-63.9%
Q3 24
-555.2%
Q2 24
-277.0%
0.3%
Q1 24
-199.6%
Q4 23
-6.3%
Q3 23
-103.3%
Q2 23
-188.0%
EPS (diluted)
CAPR
CAPR
CHSN
CHSN
Q2 25
$-2.87
Q4 24
$-0.11
Q3 24
$-0.38
Q2 24
$-0.35
$0.15
Q1 24
$-0.31
Q4 23
$0.02
Q3 23
$-0.25
Q2 23
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAPR
CAPR
CHSN
CHSN
Cash + ST InvestmentsLiquidity on hand
$151.5M
$22.1M
Total DebtLower is stronger
$4.5M
Stockholders' EquityBook value
$145.5M
$24.5M
Total Assets
$170.5M
$51.6M
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAPR
CAPR
CHSN
CHSN
Q2 25
$22.1M
Q4 24
$151.5M
Q3 24
$85.0M
Q2 24
$29.5M
$4.1M
Q1 24
$39.9M
Q4 23
$39.5M
Q3 23
$28.5M
Q2 23
$37.8M
Total Debt
CAPR
CAPR
CHSN
CHSN
Q2 25
$4.5M
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Q2 23
Stockholders' Equity
CAPR
CAPR
CHSN
CHSN
Q2 25
$24.5M
Q4 24
$145.5M
Q3 24
$68.3M
Q2 24
$11.5M
$12.1M
Q1 24
$18.4M
Q4 23
$22.6M
Q3 23
$-1.8M
Q2 23
$2.7M
Total Assets
CAPR
CAPR
CHSN
CHSN
Q2 25
$51.6M
Q4 24
$170.5M
Q3 24
$93.0M
Q2 24
$38.3M
$38.7M
Q1 24
$49.4M
Q4 23
$58.7M
Q3 23
$37.2M
Q2 23
$46.0M
Debt / Equity
CAPR
CAPR
CHSN
CHSN
Q2 25
0.18×
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Q2 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAPR
CAPR
CHSN
CHSN
Operating Cash FlowLast quarter
$-14.8M
$-390.3K
Free Cash FlowOCF − Capex
$-15.3M
FCF MarginFCF / Revenue
-137.3%
Capex IntensityCapex / Revenue
4.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAPR
CAPR
CHSN
CHSN
Q2 25
$-390.3K
Q4 24
$-14.8M
Q3 24
$-11.6M
Q2 24
$-12.3M
$806.1K
Q1 24
$-1.3M
Q4 23
$-11.6M
Q3 23
$-8.8M
Q2 23
$-9.4M
Free Cash Flow
CAPR
CAPR
CHSN
CHSN
Q2 25
Q4 24
$-15.3M
Q3 24
$-11.7M
Q2 24
$-12.3M
$771.9K
Q1 24
$-1.9M
Q4 23
$-12.2M
Q3 23
$-9.1M
Q2 23
$-9.6M
FCF Margin
CAPR
CAPR
CHSN
CHSN
Q2 25
Q4 24
-137.3%
Q3 24
-515.2%
Q2 24
-310.9%
10.2%
Q1 24
-38.3%
Q4 23
-100.5%
Q3 23
-146.5%
Q2 23
-243.9%
Capex Intensity
CAPR
CAPR
CHSN
CHSN
Q2 25
Q4 24
4.4%
Q3 24
0.4%
Q2 24
1.5%
0.5%
Q1 24
12.4%
Q4 23
4.6%
Q3 23
4.4%
Q2 23
3.5%
Cash Conversion
CAPR
CAPR
CHSN
CHSN
Q2 25
Q4 24
Q3 24
Q2 24
34.43×
Q1 24
Q4 23
Q3 23
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons